We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · March 16, 2021

Alterations in BAP1 Are Associated With Cisplatin Resistance in Malignant Pleural Mesothelioma

Clinical Cancer Research

 

Additional Info

Clinical Cancer Research
Alterations in BAP1 Are Associated With Cisplatin Resistance Through Inhibition of Apoptosis in Malignant Pleural Mesothelioma (MPM)
Clin. Cancer Res 2021 Feb 05;[EPub Ahead of Print], K Oehl, B Vrugt, U Wagner, MB Kirschner, M Meerang, W Weder, E Felley-Bosco, B Wollscheid, K Bankov, MC Demes, I Opitz, PJ Wild

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading